Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Burning Rock of Guangzhou Raises $126 Million for NGS Diagnostics

publication date: Feb 14, 2019

Burning Rock Biotech, a Guangzhou diagnostics company, closed a $126 million Series C financing led by GIC (the Sovereign Wealth Fund of Singapore). Burning Rock specializes in oncology diagnostics for precision medicine based on Next-Gen Sequencing. So far, the company has developed 32 products for different cancer types and clinical applications. It will use the proceeds of the funding to develop tests for early detection of cancer and to expand sales and marketing for its companion diagnostics business. Burning Rock also offers CRO services. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital